Esophageal adenocarcinoma (EAC) is a highly lethal cancer, with a five-year survival rate of less than 20 percent. Although a precursor lesion to EAC, called Barrett’s esophagus (BE), is present in roughly seven percent of middle-aged adults, less than one percent of BE patients will progress to EAC, making it difficult to determine which individuals are at risk of developing this deadly cancer.
RUSH Adopts Suki AI Assistant to Reduce Clinician Burnout
What You Should Know: Suki, the leader in voice artificial intelligence (AI) technology for healthcare, today announced that RUSH University System for Health, an academic health